Education
About Us
Working with TipRanks
Follow Us
Beta Bionics, Inc. (BBNX)
:BBNX
BBNX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$18.67 - $24.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)458.56K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)4.22M
Price to Earnings (P/E)―
Beta-1.29
Next Earnings
Mar 25, 2025EPS Estimate
-1.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding43,334,340
10 Day Avg. Volume259,468
30 Day Avg. Volume458,559
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)19.19
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$26.43Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering7
---
Bulls Say, Bears Say
Bulls Say
Market PotentialThe insulin-dependent Diabetes opportunity is large and still underpenetrated, offering a significant market for Beta Bionics to capture.
Product InnovationBBNX's iLet insulin pump simplifies insulin-dosing for insulin-intensive diabetic patients with its differentiated closed-loop algorithm.
Bears Say
CompetitionThere are big players in the category, such as Medtronic and Tandem, that will continue to innovate their own products.
---
Options Prices
Currently, No data available
---
Ownership Overview
9.14%
Insiders
―
Mutual Funds
― Other Institutional Investors
90.86% Public Companies and
Individual Investors
BBNX FAQ
What was Beta Bionics, Inc.’s price range in the past 12 months?
Beta Bionics, Inc. lowest stock price was $18.67 and its highest was $24.50 in the past 12 months.
What is Beta Bionics, Inc.’s market cap?
Currently, no data Available
When is Beta Bionics, Inc.’s upcoming earnings report date?
Beta Bionics, Inc.’s upcoming earnings report date is Mar 25, 2025 which is in 21 days.
How were Beta Bionics, Inc.’s earnings last quarter?
Currently, no data Available
Is Beta Bionics, Inc. overvalued?
According to Wall Street analysts Beta Bionics, Inc.’s price is currently Undervalued.
Does Beta Bionics, Inc. pay dividends?
Beta Bionics, Inc. does not currently pay dividends.
What is Beta Bionics, Inc.’s EPS estimate?
Beta Bionics, Inc.’s EPS estimate is -1.22.
How many shares outstanding does Beta Bionics, Inc. have?
Beta Bionics, Inc. has 43,334,340 shares outstanding.
What happened to Beta Bionics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Beta Bionics, Inc.?
Currently, no hedge funds are holding shares in BBNX
---
Company Description
Beta Bionics, Inc.
Beta Bionic is a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. Our product, the iLet Bionic Pancreas (iLet), is the first insulin delivery device cleared by the U.S. Food and Drug Administration to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake.
---
BBNX Stock 12 Month Forecast
Average Price Target
$26.43
Technical Analysis
Best Analysts Covering BBNX
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+1.70%
initiated a buy rating 8 days ago
Copying Mike Kratky's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +1.70% per trade.
---